Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
McKinsey
Harvard Business School
Boehringer Ingelheim
McKesson

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

Drug Price Trends for LEVOCARNITINE

See Plans and Pricing

« Back to Dashboard

Drug Price Trends for LEVOCARNITINE

Average Pharmacy Cost for LEVOCARNITINE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
LEVOCARNITINE 1 G/10 ML SOLN 50383-0171-04 0.26686 ML 2019-11-20
LEVOCARNITINE 1 G/10 ML SOLN 64980-0503-12 0.26686 ML 2019-11-20
LEVOCARNITINE 1 G/10 ML SOLN 50383-0171-04 0.28042 ML 2019-10-23
LEVOCARNITINE 1 G/10 ML SOLN 64980-0503-12 0.28042 ML 2019-10-23
LEVOCARNITINE 1 G/10 ML SOLN 64980-0503-12 0.29165 ML 2019-09-18
LEVOCARNITINE 1 G/10 ML SOLN 50383-0171-04 0.29165 ML 2019-09-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for LEVOCARNITINE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
LEVOCARNITINE 250MG CAP Major Pharmaceuticals 00536-7410-08 60 17.35 0.28917 EACH 2018-12-01 - 2023-11-30 FSS
LEVOCARNITINE 250MG CAP Major Pharmaceuticals 10006-0730-26 60 17.35 0.28917 EACH 2019-06-01 - 2023-11-30 FSS
LEVOCARNITINE 1GM/10ML LIQUID Golden State Medical Supply, Inc. 50383-0171-04 118ML 19.16 0.16237 ML 2018-01-01 - 2022-12-31 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Dow
McKesson
AstraZeneca
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.